DelistingApr 15, 2026, 04:31 PM
BioCardia Receives Nasdaq Delisting Notice for Low Equity
AI Summary
BioCardia, Inc. received a notice from Nasdaq on April 10, 2026, indicating non-compliance with the minimum stockholders' equity requirement for continued listing. The company's stockholders' equity of $895,000 as of December 31, 2025, falls below the $2.5 million threshold. The notice does not immediately affect the trading of its common stock, and BioCardia plans to submit a compliance plan to Nasdaq by May 25, 2026.
Key Highlights
- BioCardia received a delisting notice from Nasdaq on April 10, 2026.
- The company's stockholders' equity was $895,000 as of December 31, 2025.
- This is below Nasdaq's minimum requirement of $2.5 million.
- BioCardia has until May 25, 2026, to submit a compliance plan.
- An extension of up to 180 days may be granted if the plan is accepted.